Kurs
+8,88%
Likviditet
0,09 MDKK
Kalender
Est. tid* | ||
2025-11-06 | 09:00 | Kvartalsrapport 2025-Q3 |
2025-08-21 | 09:00 | Kvartalsrapport 2025-Q2 |
2025-05-19 | N/A | X-dag ordinarie utdelning STENO 0.00 DKK |
2025-05-08 | 09:00 | Kvartalsrapport 2025-Q1 |
2025-02-27 | - | Bokslutskommuniké 2024 |
2024-12-18 | - | Extra Bolagsstämma 2024 |
2024-11-07 | - | Kvartalsrapport 2024-Q3 |
2024-08-21 | - | Kvartalsrapport 2024-Q2 |
2024-05-16 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
2024-05-15 | - | Årsstämma |
2024-05-02 | - | Kvartalsrapport 2024-Q1 |
2024-02-22 | - | Bokslutskommuniké 2023 |
2023-11-09 | - | Kvartalsrapport 2023-Q3 |
2023-08-17 | - | Kvartalsrapport 2023-Q2 |
2023-06-20 | - | Kvartalsrapport 2023-Q1 |
2023-06-13 | - | Extra Bolagsstämma 2023 |
2023-05-22 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
2023-02-23 | - | Bokslutskommuniké 2022 |
2022-11-18 | - | Extra Bolagsstämma 2022 |
2022-11-09 | - | Kvartalsrapport 2022-Q3 |
2022-08-18 | - | Kvartalsrapport 2022-Q2 |
2022-05-20 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
2022-05-19 | - | Årsstämma |
2022-05-05 | - | Kvartalsrapport 2022-Q1 |
2022-02-24 | - | Bokslutskommuniké 2021 |
2021-11-04 | - | Kvartalsrapport 2021-Q3 |
2021-08-19 | - | Kvartalsrapport 2021-Q2 |
2021-05-21 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
2021-05-20 | - | Årsstämma |
2021-05-06 | - | Kvartalsrapport 2021-Q1 |
2021-02-25 | - | Bokslutskommuniké 2020 |
2020-11-05 | - | Kvartalsrapport 2020-Q3 |
2020-08-20 | - | Kvartalsrapport 2020-Q2 |
2020-05-15 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
2020-05-14 | - | Årsstämma |
2020-05-07 | - | Kvartalsrapport 2020-Q1 |
2020-02-26 | - | Bokslutskommuniké 2019 |
2019-11-06 | - | Kvartalsrapport 2019-Q3 |
2019-08-20 | - | Kvartalsrapport 2019-Q2 |
2019-05-07 | - | Kvartalsrapport 2019-Q1 |
2019-02-21 | - | Bokslutskommuniké 2018 |
Beskrivning
Land | Danmark |
---|---|
Lista | First North Denmark |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("Stenocare") has delivered the first shipment of its new CBD100 Oil product to the Danish market. With this new medical cannabis oil product, Stenocare now offers four different prescription-based medical cannabis oil products to Danish patients, making it the leading provider of oil products in the Danish Pilot Programme
Since 2018, Stenocare has been a leading supplier of prescription-based medical cannabis oil products in the Danish Pilot Programme. The company already offers a THC30 Oil product, a CBD20 Oil product, and a THC/CBD Oil product. Now, Stenocare is adding its CBD100 Oil product to the portfolio-providing patients with even more treatment options and further strengthening its position as a leading provider of medical cannabis oil products in the Pilot Programme.
The new product is named CBD100 Oil Stenocare, and it contains 100 mg/ml CBD and 5 mg/ml THC in a 30 ml bottle. The first shipment of CBD100 has just been delivered in Denmark and is now available to patients across the country.
Sign-up for Stenocare news here: https://stenocare.com/subscribe-for-newsletter/ to automatically receive the latest news and information about the company.
For additional information regarding STENOCARE, please contact:
Thomas Skovlund Schnegelsberg, CEO Phone: +45 31770060 E-mail: presse@stenocare.com